Kazia Therapeutics Limited (KZIA)
KZIA has a market cap or net worth of $14.13 million. The enterprise value is $11.85 million.
The next estimated earnings date is Friday, December 8, 2023, before market open.
|Earnings Date||Dec 8, 2023|
KZIA has 23.63 million shares outstanding.
|Owned by Insiders (%)||n/a|
|Owned by Institutions (%)||1.17%|
|EV / Earnings||n/a|
|EV / Sales||747.17|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.15.
|Debt / Equity||0.15|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -135.00% and return on invested capital (ROIC) is -174.23%.
|Return on Equity (ROE)||-135.00%|
|Return on Assets (ROA)||-64.00%|
|Return on Capital (ROIC)||-174.23%|
|Revenue Per Employee||n/a|
|Profits Per Employee||n/a|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -1.92% in the last 52 weeks. The beta is 2.16, so KZIA's price volatility has been higher than the market average.
|52-Week Price Change||-1.92%|
|50-Day Moving Average||0.76|
|200-Day Moving Average||1.01|
|Relative Strength Index (RSI)||41.64|
|Average Volume (30 Days)||70,326|
Short Selling Information
|Short Previous Month||113,747|
|Short % of Shares Out||0.12%|
|Short % of Float||n/a|
|Short Ratio (days to cover)||0.08|
In the last 12 months, KZIA had revenue of $15,862 and -$14.11 million in losses. Loss per share was -$0.74.
|Loss Per Share||-$0.74|
The company has $3.47 million in cash and $1.19 million in debt, giving a net cash position of $2.28 million or $0.10 per share.
|Cash & Cash Equivalents||3.47M|
|Net Cash Per Share||$0.10|
|Equity / Book Value||7.98M|
|Book Value Per Share||0.34|
|Operating Cash Flow||-10.04M|
|Free Cash Flow||-10.04M|
|FCF Per Share||-$0.61|
Gross margin is 96.05%, with operating and profit margins of -100,747.06% and -88,978.65%.
Dividends & Yields
KZIA does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for KZIA is $2.00, which is 234.45% higher than the current price. The consensus rating is "Strong Buy".
|Price Target Difference||234.45%|
|Analyst Consensus||Strong Buy|
|Revenue Growth Forecast (5Y)||387.84%|
|EPS Growth Forecast (5Y)||n/a|
The last stock split was on July 14, 2017. It was a reverse split with a ratio of 1:4.
|Last Split Date||Jul 14, 2017|
KZIA has an Altman Z-Score of -5.94 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.